Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

M Banach, C Serban, S Ursoniu, J Rysz… - Pharmacological …, 2015 - Elsevier
Statin therapy may lower plasma coenzyme Q10 (CoQ10) concentrations, but the evidence
as to the significance of this effect is unclear. We assessed the impact of statin therapy on …

Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference

GBJ Mancini, S Baker, J Bergeron, D Fitchett… - Canadian Journal of …, 2011 - Elsevier
While the proportion of patients with significant statin-associated adverse effects or
intolerance is very low, the increasing use and broadening indications have led to a …

III Diretriz brasileira de insuficiência cardíaca crônica

EA Bocchi, FGM Braga, SMA Ferreira… - Arquivos Brasileiros …, 2009 - SciELO Brasil
O objetivo desta Diretriz é servir de apoio e auxiliar os médicos nas decisões referentes aos
seus pacientes, elaborando orientações que podem ser úteis na prática médica. A adoção …

Statin therapy and risks for death and hospitalization in chronic heart failure

AS Go, WY Lee, J Yang, JC Lo, JH Gurwitz - Jama, 2006 - jamanetwork.com
ContextWhether statin therapy has beneficial effects on clinical outcomes in patients with
heart failure is unclear. ObjectiveTo evaluate the association between initiation of statin …

Coenzyme Q10 An Independent Predictor of Mortality in Chronic Heart Failure

SL Molyneux, CM Florkowski, PM George… - Journal of the American …, 2008 - jacc.org
Objectives: The aim of this study was to investigate the relationship between plasma
coenzyme Q10 (CoQ10) and survival in patients with chronic heart failure (CHF) …

Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta‐analysis

N Suksomboon, N Poolsup… - Journal of clinical …, 2015 - Wiley Online Library
What is known and objective CoenzymeQ10 (CoQ10), or ubiquinone, is an endogenous
enzyme cofactor produced by most human cells. It is a potent antioxidant and is necessary …

Micronutrient deficiencies: an unmet need in heart failure

V Soukoulis, JB Dihu, M Sole, SD Anker… - Journal of the American …, 2009 - jacc.org
Heart failure (HF) is a common, disabling, and costly disease. Despite major advances in
medical therapy, morbidity and mortality remain high, in part because current …

Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy

K Ramasubbu, J Estep, DL White, A Deswal… - Journal of the American …, 2008 - jacc.org
Over the past 2 decades our understanding of the pathologic mechanisms that lead to heart
failure (HF) has evolved from simplistic hemodynamic models to more complex models that …

Statins and mortality among elderly patients hospitalized with heart failure

JAM Foody, R Shah, D Galusha, FA Masoudi… - Circulation, 2006 - Am Heart Assoc
Background—Small studies suggest that statins may improve mortality in patients with heart
failure (HF). Whether these results are generalizable to a broader group of patients with HF …

[HTML][HTML] Coenzyme Q10: is there a clinical role and a case for measurement?

SL Molyneux, JM Young, CM Florkowski… - The Clinical …, 2008 - ncbi.nlm.nih.gov
Abstract Coenzyme Q 10 (CoQ 10) is an essential cofactor in the mitochondrial electron
transport pathway, and is also a lipid-soluble antioxidant. It is endogenously synthesised via …